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The lymphocytosis-promoting factor (LPF) 1 of phase I  Bordetella  pertussis  induces 
lymphocytosis in a  variety of experimental animals  (1-3).  The marked  increase in 
recirculating lymphocytes is a result of a redistribution of cells from lymphoid tissue 
to the blood (4-6) which, in part, is related to the inability of cells to home from the 
blood  into  lymph  nodes  at  a  normal  rate  (7,  8).  In  addition  to  induction  of 
lymphocytosis, purified LPF also causes sensitization of mice to the lethal effects of 
histamine and unresponsiveness to the hyperglycemic effect of epinephrine (9). 
Although  in  vivo lymphocytosis is  not  associated with  lymphocyte proliferation, 
LPF is a  potent mitogen for both murine  (10,  11)  and human  (12)  lymphocytes in 
vitro.  LPF is clearly a  T-cell mitogen for mouse lymphoeytes, but the proliferative 
response requires the presence of an accessory cell-surface immunoglobulin (sIg  +) cell 
(13). In this paper, LPF is shown also to induce cytotoxic effector lymphocytes (CEL) 
in vitro that are active against  both syngeneic and allogeneic tumor cells, as well as 
allogeneie normal cells. 
Materials and Methods 
Mice.  Female CBA/J, BALB/cJ, DBA/2J, and C57BL/6J mice, 8-12 wk old, were obtained 
from The Jackson Laboratory, Bar Harbor, Maine or from The Jackson Laboratory stock bred 
in this department. 
Lymphocytosis-Promoting  Factor (LPF),  Concanavalin  A  (Con A),  and  Phytohemagglutinin-P 
(PHA).  LPF was isolated  from culture supernatant fluids of phase I B. pertussis strain NIH 
114 by previously described methods (9). Con A was obtained from Pharmacia Fine Chemicals, 
Div. of Pharmacia Inc., Piscataway,  N. J. and PHA (PHA-P) from Difco Laboratories, Detroit, 
Mich. 
Lymphoid  Cell  Suspensions.  Unless  otherwise  indicated, the medium used  throughout was 
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CEL, cytotoxic effector lymphocytes; CMC, cell-mediated cytotoxicity; (]on A, concanavalin A; FCS, fetal 
calf serum; LPF, lymphocytosis-promoting factor isolated from Bordetella pertussis;  LPS, lipopolysaccharide 
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Rosweil Park Memorial Institute medium-1640 (RPMI-1640)  (Grand Island Biological Co., 
Grand Island, N. Y.)  supplemented with 5% heat-inactivated fetal calf serum (FCS)  (Reheis 
Chemical  ~  Co., Div. of Armour Pharmaceuticals, Chicago, Ill.), 100 U/ml penicillin, and 100 
#g/ml streptomycin. Mice were killed by cervical dislocation. Spleen and peripheral lymph 
nodes (inguinal and axillary) were aseptically removed and teased with forceps  in medium. 
Tissue fragments were  allowed to  sediment and  the  supernate containing single cells  was 
aspirated. Cell suspensions were centrifuged, washed once, and resuspended in fresh medium. 
Viability was assessed  with the trypan blue dye exclusion test, and only preparations with 
>90% cell viability were utilized. 
Preparation of LPF Effector Cells.  In all experiments, 4  ×  106 viable spleen or peripheral 
lymph node cells/ml were mixed with an equal volume of medium containing  4 #g/ml of LPF 
and 2.0-ml aliquots were incubated in tubes at 37°C in a humid atmosphere of 5% CO2 in air. 
After 72 h, the cells were harvested, washed once, and resuspended in fresh medium. 
Peritoneal Macrophages.  Mice were  killed by cervical dislocation and the  abdominal skin 
reflected.  2  ml of RPMI-1640 with  20%  FCS  was  injected intraperitoneally and the  fluid 
aspirated with a Pasteur pipette. The peritoneal exudate cells were washed once and viability 
was  determined by  the  trypan  blue dye  exclusion test.  The  cells  were  resuspended  to  a 
concentration of 2  ×  106/ml and 25-ml aliquots were dispensed to 100-mm Petri dishes. After 
incubation in a 5% COz incubator at 37°C for 60 rain, the nonadherent cells were removed and 
the  adherent cells  were washed  once in  10  ml of RPMI-1640-20% FCS. The washing was 
repeated after an additional 60 min of incubation. At the end of a 20-24-h incubation period, 
the adherent cells were scraped from the glass surface with a rubber policeman. 
LPS Blast Cells.  2  ×  10  spleen cells were cultured with  10 #g of LPS (Salmonella typhosa, 
Difco Laboratories  ) in a final volume of 1 ml in a 5% COz incubator at 37°C for 48 h. The cells 
were then harvested and washed in fresh medium. Cells were resuspended in RPMI-1640 with 
10% bovine serum albumin (BSA) at a concentration of 50-70 ×  10  cells/ml. 1 ml of the cell 
suspension was layered on 4 ml of RPMI-1640-23% BSA and after centrifugation at  13,000 g 
for  30 min at 4°C, the lipopolysaccharide endotoxin (LPS)  blast cells were collected at  the 
interface. 
Separation of Lymphocytes.  Spleen cells,  stimulated with  LPF  for  72  h,  were  separated  in 
discontinuous BSA density gradients using the methods of Raidt et al.  (14) and Adler et al. 
(15).  35.1% BSA (Path-o-cyte 4,  Miles Laboratories Inc., Miles Research  Products, Elkhart, 
Ind.) was diluted appropriately in RPMI-1640 and  1.7-ml layers of 29 and 23%  BSA were 
placed in cellulose nitrate tubes. 150-200  ×  106 cells from LPF-stimulated cultures in 1.6 ml 
of 10% BSA were placed on top of the gradient. The tubes were then centrifuged at 13,000 g for 
30  min at  4°C.  Discrete bands of cells  were  collected at  the  interfaces, washed  once, and 
viability determined by the trypan blue exclusion test. 
Determination of DNA Synthesis.  Methods previously described in detail were employed (10). 
Briefly,  triplicate cultures  in  microtiter wells  containing 0.5  ×  l06  cells  and  an  optimal 
concentration of mitogen in 0.25 ml of medium were harvested on glass-fiber filter paper after 
an 8-h pulse with 2.0/tCi of SH-thymidine, sp. act. 6.0 Ci/mM (Schwarz/Mann Div. Becton, 
Dickinson, & Co., Orangeburg, N. Y.). The dried filters were placed in 5 ml of an omnifluor- 
toluene scintillation mixture (New England Nuclear, Boston, Mass.)  and counted. Results are 
expressed  as counts per minute ±  standard deviation. 
Target Cells.  P815, a  DBA/2 mastocytoma; EL4, a  C57Bl/b lymphoma; L1210,  DBA/2 
lymphoma; PU-5 and $49, BALB/C lymphomas; and J744, a BALB/c macrophage tumor were 
maintained in medium. After a  single wash with fresh  medium, 5  ×  106 tumor cells  were 
labeled with 200 Ci of Na2CrO4  (Amersham Corp., Arlington Heights, Ill.) in a  1.0-ml vol for 
1 h  at  37°C.  The  target  cells  were  then  washed  four  times  with  fresh  medium.  Normal 
macrophages and LPS blast cells to be used as target cells, were labeled with 51Cr in the same 
fashion. 
Cytotoxic Assays.  4  ×  104 labeled target cells in 0.2 ml of medium were added to 0.25 ml of 
an appropriate number of effector cells in triplicate. After 5 h at 37°C, 2.0 ml of medium was 
added to each tube and the tubes centrifuged at 250 g for 10 min. 1 ml of the supernate was 
removed, and assayed for SlCr release  in an Intertechnique (Fairfield, N. J.) gamma counter. 
The percent specific lysis was calculated according to the formula: AH  SWEE KONG  AND STEPHEN  I.  MORSE  1395 
SXCr release in the presence of stimulated lymphocytes 
-  51Cr release in the presence of control cells 
×  100. 
maximum 5aCr release -  51Cr release in the presence of control cells 
The maximum 51Cr release from target cells was determined by rapidly freezing and thawing 
4  ×  104 labeled target cells four times. 
Mitomycin C Treatment.  Mitomycin C  (Sigma Chemical Co., St.  Louis, Mo.) was diluted to 
1 mg/mi in medium immediately before use.  0.25  ml was added per  10 ml of lymphocyte 
suspension containing  20  X  106 cells. The suspensions were then incubated at 37°C for 1 h and 
the cells washed three times before use. 
Thy-l.2  Antiserum and  Rabbit Anti-Mouse  Thymocyte Serum (ATS).  T  cells  were  lysed  by 
treatment with Thy-l.2 antiserum plus guinea pig complement. The sera were prepared and 
characterized as described previously (16). Thy-l.2 antiserum and normal AKR serum were 
heat  inactivated at  56°(]  for  30  min before  use.  ATS was  obtained from  Microbiological 
Associates,  Walkersville, Md. ATS and control normal rabbit serum (NRS) were heat inacti- 
vated at 56°C for 30 rain before use. 
Results 
Induction of Cytotoxic Activity  in Spleen and PLN Cultures by LPF.  Initial experiments 
were performed to test whether spleen or PLN of CBA mice, incubated with LPF for 
72 h, demonstrated a cytotoxic effect against allogeneic P815 mastocytoma cells. The 
dose of LPF chosen was the same as that which produced an optimal mitogenic effect, 
2  /~g/ml  of LPF per  2  ×  106 cells/ml;  this  dose was  subsequently shown  also  to 
generate maximal production of cytotoxic cells. Mitogen was not added to the mixture 
of cells in the cytotoxic assay. Fig.  1 presents the results of a typical experiment and 
it can be seen that both the stimulated spleen cells and PLN demonstrated cytotoxic 
activities over a broad range of effector:target cell ratios. 
The relationship  between  the  time-course of proliferation as  measured  by  [3H]- 
thymidine  uptake,  and  the  generation  of cytotoxic  cells  in  spleen  cell  cultures 
containing LPF was next examined. It can be seen in Fig. 2 that whereas incorporation 
of [SH]thymidine was ----78% of maximum at 48 h, cytotoxicity was virtually absent. 
Maximal [~H]thymidine incorporation was at 72 h and now the cytotoxic activity was 
marked. At 96 h, the proliferative response had decreased to 44% of the peak value, 
but cytotoxic activity remained elevated. Thus, there was a 24-h time lag between the 
development of the proliferative response and expression ofcytotoxicity; furthermore, 
cytotoxic activity, once reaching  a  peak  at  72  h,  remained  elevated whereas  3H- 
thymidine incorporation decreased. 
It  was  shown  that  the  cytotoxic effects were  not  a  result  of soluble  cytotoxins 
released by LPF-activated cells nor by LPF itself because neither culture supernate 
nor LPF, in amounts (0.5-1.0/tg)  vastly exceeding that which could be carried over 
in free form by the washed cells, caused 51Cr release from P815 cells. 
Effect  of Mitomycin  C on  the Generation and Activity  of Cytotoxic Cells.  Although  the 
times of peak proliferation and maximal cytotoxic activity were the same  (72 h), it 
was not clear whether DNA synthesis was required for production of effector cells. As 
shown in Table I, pretreatment of CBA spleen cells with mitomycin C, an inhibitor 
of DNA synthesis, inhibited the induction of cytotoxie cells by LPF thereby indicating 
that proliferation was required. In contrast, when cells, stimulated by LPF for 72 h, 
were treated with mitomyein C, they still exerted full cytotoxic activity. 
Characterization of the LPF-Induced  Cytotoxic Cells.  To determine the nature of the 90 
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Fro.  1.  Cytotoxicity of LPF-induced effector cells against B]Cr-P815. CIBA spleen cells (0)  and 
lymph node cells (11) at concentrations of 2 ×  10S/ml were cultured with 2 p.g/ml of LPF for 72 h 
and assayed for cytotoxic  activity. Data are expressed as mean percent lysis  of triplicate assays  after 
5h. 
cytotoxic effector cell, CBA spleen cells, previously incubated for 72 h with LPF, were 
separated on a discontinuous BSA gradient, and the cytotoxic activity of the fractions 
was examined.  The  gradient  was  designed  to separate LPF-stimulated spleen  cells 
into low density transformed or blast-like cells and high density small lymphocytes. 
Cells collected from the less dense fraction, consisting of over 80% transformed cells 
with the electron microscopical appearance of T-cell blasts, showed enhanced target 
cell lysis at all effector:target cell ratios tested, compared to the unseparated spleen 
cells (Fig. 3). However, cells from the high density fraction, which were predominately 
small lymphocytes, expressed little or no cytotoxic effect. Thus, the cytotoxic effector 
cells were blast like and not small lymphocytes. 
Inhibition of LPF-Induced Cytotoxicity by ATS and Thy-l.2 Antiserum.  Previous work 
demonstrated that the cells proliferating in response to LPF are T  cells (11).  Because 
blast-like cells were  shown  to  be  the  effector cells,  it  was of interest  to  determine 
conclusively whether these cytotoxic cells were transformed T  lymphocytes. Kirchner 
and Blaese  (17)  reported that  preincubation  of PHA and Con A-induced cytotoxic 
effector cells with anti-thymocyte serum inhibited  the lysis of target cells. It can be 
seen in Fig. 4 that the addition of different dilutions of ATS to the mixture composed 
of LPF-stimulated CBA spleen cells and P815  cells decreased the amount of target 
cell  lysis.  More  than  50%  inhibition  was  obtained  with  a  1:100  dilution  of the 
antiserum and with higher concentration, cytotoxicity was virtually abolished. NRS 
had no effect. AH SWEE KONG AND STEPHEN I. MORSE  1397 
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FIG. 2.  Relationship  between the time-course  of the proliferative  response (&) and the generation  6  of cytotoxic  effector  cells (4)) induced by LPP. Stimulation of 0.5 ×  10  CBA spleen cells by 0.5 #g 
LPF in microtiter wells was measured by the incorporation  of [3H]thymidine  and compared with 
cytotoxicity  at an effector:target  cell ratio of 30:1 against 5]Cr-PS15 cells at various time periods. 
As also shown in Fig. 4, when CBA spleen cells, cultured with LPF for 72 h, were 
treated with different dilutions of Thy-l.2 antiserum plus complement, cytotoxicity 
was diminished. Normal mouse serum plus complement had no effect. Collectively, 
the data show that the LPF-induced cytotoxic cells, like the proliferating cells, are T 
cells. 
Comparison of Activity of Cytotoxic Cells Induced by  LPF,  Con  A,  and PHA.  It  has 
previously been  shown  that  full  activity of cytotoxic effector lymphocytes  (CEL), 
generated by Con A or PHA, requires the addition of mitogen to the cytotoxic assay 
(18,  19).  In  contrast,  expression  of cytotoxicity by  LPF-generated  CEL  does not 
require exogenous mitogen. The results present in Table II demonstrate this difference. 
After a  72-h  incubation of spleen cells with optimal amounts of mitogen, the cells 
were tested for cytotoxicity against  P815. In the case of CBA, BALB/c, and DBA/2 
spleen cells cultured with LPF, marked specific lysis occurred, whereas both Con A- 
and PHA-stimulated cells produced only minimal target cell lysis.  However, because 
LPF can be demonstrated on the surface of the effector cells by immunofluorescent 
techniques using monospecific LPF antiserum, it is possible that the cell-surface LPF 
subserves the function of additional  mitogen in  the cytotoxic assay.  Indeed, it was 
shown that the cytotoxic activity of Con A-stimulated spleen cells could be markedly 
enhanced by adding LPF, as well as Con A  or PHA, to the cytotoxic assay system 
(Fig. 5). 1398  CYTOTOXIC LYMPHOCYTES 
TAnLE I 
Effect of Mitomycin C on the Generation of Cytotoxic Cells by LPF 
Mitomycin treatment  [nH]thymidine incorporation 
Cytotoxic index 
15:1"  30:1" 
None  32,115:1:1,253.8  71  82 
Prestimulation  261  :t: 24.5  1  0 
Poststimulation  ND:~  61  83 
CBA spleen cells were treated with mitomycin C  before culturing with LPF  (prestimulation) or after 
culturing  for  72  h  and  before  mixing  with  51Cr-P815  cells  (poststimulation).  Incorporation  of aH- 
thymidine was also measured at 72 h. 
* Effector: target cell ratio. 
:~ Not determined. 
Specificity ofCytotoxic Lymphocytes Induced by LPF.  In Table II it is seen that not only 
spleen cells from allogeneic CBA  (H-2  k)  mice, but also spleen cells from syngeneic 
BALB/c and  DBA/2  mice  (both  H-2  d)  formed  CEL  active  against  P815  (H-2  d) 
mastocytoma cells  when  stimulated  by  LPF.  Thus,  the  effector cells  were  active 
against both allogeneic and syngeneic tumor cells with respect to the H-2 haplotype. 
Furthermore,  LPF-induced  effector cells  in  CBA  spleen  cell  cultures  were  active 
against a variety of allogeneic tumor cells (Table III). The extent of lysis varied with 
the  cell  type,  and  in  the  case  of EL4,  it  was  shown  that  these  cells  are  highly 
susceptible to lysis by cytotoxic cells generated in a mixed lymphocyte reaction, even 
though relatively low cytotoxicity occurred with LPF-induced cells. Thus, the suscep- 
tibility of allogeneic tumor cells to lysis by LPF-activated cytotoxic cells is not directly 
correlated with the major histocompatibility locus. 
Having demonstrated that  LPF-induced  killer cells  were  effective against  both 
syngeneic and allogeneic tumor cells, their effect on syngeneic and allogeneic normal 
cells was examined. For these experiments the effector cells were derived from BALB/ 
c  (H-2  d) spleen cell cultures. Target cells were the syngeneic tumor macrophage cell- 
line J774,  normal syngeneie BALB/c macrophages, and allogeneic C57B1/6  (H-2  b) 
macrophages. LPF-stimulated BALB/c spleen cells were also tested against blast cells 
from BALB/c and CBA  (H-2  k)  mice which had been induced by culturing spleen 
cells with LPS. 
The results of these experiments are shown in Figs. 6 and 7 and demonstrate that 
LPF-induced cytotoxic cells are active against allogeneic, but not syngeneic, normal 
cells although they kill both allogeneic and syngeneic tumor cells. 
Discussion 
The results of experiments presented herein show clearly that the lymphocytosis- 
promoting factor of B. pertussis,  in addition to being an in vitro T-cell mitogen for 
mouse spleen cell or PLN cultures, causes the generation of cytotoxic effector lym- 
phocytes in cultures of these cells. The effector cells are of low density and are blast 
like in appearance under the light microscope and have the electron microscopical 
features of T-cell lymphoblasts. Their effector function is blocked by ATS, and, more 
importantly, the cytotoxic cells are lysed by anti-Thy 1 antiserum and complement. AH  SWEE  KONG  AND  STEPHEN  I.  MORSE  1399 
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Fro. 3.  Cytotoxic  activity of cell fractions  isolated on a discontinuous BSA gradient. CBA spleen 
cells were cultured with LPF for 72 h. Unseparated stimulated spleen cells (11), stimulated low 
density cells (0) and stimulated high density cells (A) were assayed for cytotoxicity  against 51Cr- 
P815 cells at various  effector:target  cell ratios. 
Thus the cytotoxic cells are T-cells. These findings parallel those of Clark  (20)  who 
demonstrated that blast cells are the CEL induced by Con A. Soluble factors did not 
appear to be involved in cytotoxicity because neither culture supernatant  fluids of 
LPF-stimulated cells nor LPF itself were toxic for target cells. 
Preincubation  of spleen  cells  with  mitomycin  C  before  incubation  with  LPF, 
blocked the  generation  of cytotoxic cells  and,  as  in  the  case of the  production of 
alloimmune  effector T  cells  (21),  indicates  that  proliferation  of at  least  one  cell 
population is  a  prerequisite.  (However, the expression of cellular cytotoxic activity 
does not require DNA synthesis because mitomycin C  did not block the activity of 
LPF-stimulated ceils.) In preliminary experiments, it also appears that the generation 
of CEL by LPF, like the proliferative T-cell response, is completely dependent upon 
the presence of a  nonproliferating accessory sIg  + cell (B cell)  (13). Interestingly, the 
kinetics of maximal 3H-thymidine incorporation and the generation of cytotoxic cells 
were different. The 24-h time lag between the appearance of proliferation and CEL 
suggests that one or more populations of T  cells might be involved in LPF-induced 
cytotoxicity; unpublished studies, A. S. Kong, have indicated that the precursors of 
proliferating cells and of cytotoxic effector cells have similar radiation sensitivity. 
None  of the  above  findings  conclusively shows  that  the  cells  undergoing  DNA 
synthesis are the same cells that become effector cells. For example, T-cell interactions 
may take place. Evidence of T-T collaboration in the generation of cytotoxic activity 
is well documented (22, 23), although the mechanism of interaction remains unknown. 1400  CYTOTOXIC  LYMPHOCYTES 
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FIo. 4.  Effect  of anti-thymocyte serum and Thy-1.2 antiserum plus complement on LPF-induced 
effector cells. CBA spleen cells at a concentration of 2 ×  106 ceils/ml were cultured with 2/~g/ml 
of LPF. Cytotoxicity against 51Cr-P815 was determined at an effector:target cell ratio of 30: I in the 
presence of various dilutions of ATS or normal rabbit serum (1:25) (0). In another experiment the 
effector cells were treated with different dilutions of Thy-1.2 antiserum or normal AKR serum (1: 
10)  plus complement  (C)). The treated  cells were washed and cytotoxic activity assessed at  an 
effector:target cell ratio of 30:1. 
In the alloimmune system, cells of the T-helper population  (ly 1  +) have been clearly 
distinguished from cells of the T-killer population (Ly 2+3  +) on the basis of their cell- 
surface phenotype (24, 25).  Recently, Pilarski et al.  (26) have shown that thymocytes 
alone stimulated  by Con A  did  not  exert  cytotoxicity, but  when  cocultured  with  a 
population of radio-resistant  spleen cells expressed a  high level of cytotoxicity. Thus, 
helper T-cells may play a  role in Con A-induced cytotoxicity. 
Previous work (10)  demonstrated that LPF was mitogenic for T  lymphocytes from 
adult spleen, PLN, and cortisone-treated thymus, but not for normal thymus or bone 
marrow cells.  Tissue  distribution  studies  indicate  that  the LPF-induced cytotoxicity 
follows a similar pattern as the mitogenic response and no significant cytotoxicity was 
shown by thymocytes cultured with LPF (A. S. Kong, unpublished  data).  There are 
three  obvious  possibilities  for  the  lack  of LPF-induced  cell  mediated  cytotoxicity 
(CMC)  of thymocyte cultures:  (a)  there  are  not  enough  B  cells  present  to exert  a 
helper  function  for T-cell proliferation;  (b)  there  is  an  insufficient  percentage  of T 
cells  in normal  thymus that  are capable of responding to LPF;  and  (c)  the thymus 
may be rich in cells that suppress the response. Preliminary experiments indicate that 
addition  of B  cells does not enhance the mitogenic response of thymocytes and  it  is 
therefore unlikely that the absence of helper cells solely accounts for unresponsiveness. AH SWEE  KONG AND STEPHEN I. MORSE  1401 
TABLE II 
The Cytotoxic Effect of Mitogen-Stimulated Allogeneic and Syngeneic Spleen Cells on ~tCr-Mastocytoma 
Cells 
Spleen cell source and H-2  haplotype  Mitogen  Cytotoxic index*  Proliferative response 
% 
CBA/J (H-2  k)  LPF  78.0  132,028 ±  5,434 
Con A  23.5  135,834 ±  5,829 
PHA  9.4  94,747 ±  615 
BALB/c (H-2  d)  LPF  90.6  92,257 ±  4,348 
Con A  5.8  134,713 ±  5,355 
PHF  12.7  65,920 +  288 
DBA/2 (H-2  e)  LPF  63.3  75,869 +  5,710 
Con A  7.1  102,927 ±  1,446 
PHA  0  1,286 ±  403 
Spleen  cells were cultured  for 72 h with  an optimal concentration  of mitogen  and 
response and generation of CEL assayed. 
* Effector: target cell ratio of 30:1. 
the proliferative 
Although  there are conflicting reports as to the requirement  for added mitogen in 
the cytotoxic assay for maximal CMC  of PHA- or Con A-stimulated cultures,  in our 
studies the requirement  in the case of Con A  was apparent  (Fig. 5). Moreover, in the 
absence  of added  mitogen,  Con  A-stimulated  cells  demonstrated  far  more  CMC 
against  allogeneic  tumor  cell  target  cells  than  against  syngeneic  tumor  cells  (Table 
II). The CMC  of PHA-stimulated  cells was too low in all cases to permit detection of 
differences related to H-2 specificity. The ability of added lectin to alter the specificity 
of effector T  cells is also seen with alloimmune T  cells which normally show exquisite 
specificity  against  cells bearing  the  aUoantigens  used  for immunization  (27).  In  the 
presence of added Con A  or PHA, specificity is lost and syngeneic tumor target cells 
may be lysed (28, 29). The role of added lectins in CMC reactions is not clear. Initially 
it  was thought  that  they  served solely to attach  the  effecto'r cells to the  target  cells 
under  circumstances  in which  the  effector cells could  not  bind  tightly  to the  target 
cells, but Asherson et al. (19)  have demonstrated that only mitogenic agglutinins  (e.g. 
PHA  and  Con  A)  but  not  nonmitogenic  agglutinins,  such  as  axinellor  and  wheat 
germ agglutinin,  promote CMC.  Hence, binding of cytotoxic T  cells to target cells is 
not sufficient to cause lysis. Rubens and Henney (30), propose that the role of Con A 
in  lectin-dependent  CMC  is  twofold:  (a)  to  provide  approximation  of effector and 
target cells; and  (b) to activate the effector cells. 
LPF-activated  cytotoxic T  cells differed  from those  activated  by Con  A  or  PHA. 
First,  extraneous  mitogen  was not  required  for maximal  lysis of target  cells  to take 
place  and  second,  both  allogeneic  and  syngeneic  tumor  cell  targets  were  equally 
susceptible.  Because  LPF-stimulated  cells  contain  surface  LPF,  the  bound  material 
might subserve the function of added mitogen. In preliminary experiments it has been 
found  that  addition  of monospecific  LPF  antiserum  to  the  CMC  assay  blocks  the 
cytotoxic reaction;  however, this may be a  result of steric hinderance  of neighboring 
cell-surface receptors rather than the specific binding of the antiserum to LPF. When 1402  CYTOTOXIC  LYMPHOCYTES 
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F1G.  5.  Cytotoxic activity of Con A-induced effector cells in the presence and absence of different 
T-cell mitogens. CBA spleen cells were cultured with Con A  for  72  h  and assayed for cytotoxicity 
against P815  cells at  an effector:target ratio of 30:1.  The cytotoxic assay was performed without 
mitogen or with LPF, Con A, or PHA added at the concentrations shown. 
LPF is added to Con A-stimulated  cells in the CMC  assay, cytotoxicity is enhanced 
in the same fashion as the enhanced activity observed when Con A or PHA are added. 
These  results  suggest,  but  by  no  means  prove,  that  the  cell-bound  LPF  on  LPF- 
induced  CEL  plays  a  critical  role  in  CMC  and  experiments  are  in  progress  to 
determine  whether  the  cells  retain  the  capacity  to  lyse  target  cells  after  LPF  is 
removed from their surface. 
LPF-activated cells lyse tumor cells of both allogeneic and syngeneic origin whereas 
Con A-induced cytotoxic cells, in the absence of added mitogen, demonstrate activity 
against allogeneic but not syngeneic tumor target cells  (Table II, and reference  31). 
The  relative  nonspecificity  of the  LPF-induced  cells  showing CMC  against  tumor 
cells is not seen when normal cells are utilized as targets.  Thus, the CEL are active 
against  both syngeneic  tumor and normal  allogeneic  macrophages  but  not against 
normal  syngeneic  macrophages.  Moreover,  the effector  cells will  kill  allogeneic  but 
not syngeneic LPS blast cells. These findings are similar to those recently reported by 
Bevan et al. (32) for Con A-induced cytotoxic cells which exhibit CMC in the absence 
of added mitogen for normal cells with an allogeneic haplotype but not for syngeneic 
normal cells. 
The target site(s) for LPF-induced cytotoxic T-cells has not been elucidated, but in 
the case of syngeneic tumor cells it is surely not the major histocompatihility complex 
because syngeneic normal cells are not susceptible. In this regard, Lundak and Raidt 
(33)  reported that DBA/2  spleen cells can be sensitized in vitro to DBA/2  mastocy- 
toma cells with the production of cells exhibiting CMC against the P815 mastocytoma. 
It will be of great importance to determine the specific point of recognition of LPF- AH  SWEE  KONG  AND  STEPHEN  I.  MORSE  1403 
TABLE  III 
The Cytotoxic Effect of LPF-Stimulated  CBA Spleen Cells on  Various Allogeneic Tumor Cells 
Tumor  H-2  Histologic type 
Cytotoxic index 
15:1  30:1 
% 
P815  d  Mastocytoma  78  88 
PU-5  d  Lymphoma  60  65 
$49  d  Lymphoma  49  62 
L 1210  d  Leukemia  40  46 
J774  d  Maerophage  76  B  1 
EL4  b  Lymphoma  28  34 
CBA spleen cells were incubated with LPF for 72 h and then assayed for cytotoxicity at effector: target cell 
ratios of 15:1 and 30:1. 
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F]c.  6.  Cytotoxicity  of LPF-induced  effector cells  against  syngeneic tumor  and  normal  cells. 
BALB/c spleen cells were cultured with LPF for 72 h and assayed for cytotoxic effect against J774 
BALB/c tumor macrophages (0) and normal BALB/c macrophages (O). 
induced CEL and whether there are different CEL populations exhibiting different 
specificities, or a limited number of populations with multiple specificities. 
Summary 
Cytotoxic effector lymphocytes were induced in cultures of mouse spleen or lymph 
node cells by lymphocytosis promoting factor  (LPF). The  LPF-activated cytotoxic 
cells:  (a)  were  not  generated  unless  proliferation occurred;  (b)  sedimented  in  the 
lighter density fraction of a bovine serum albumin gradient; (c) were large, blast-like 
cells; and (d) were lysed by Thy-l.2 antiserum plus complement and, therefore, were 
T  cells.  Neither LPF alone nor supernates from stimulated cultures were cytotoxic. 1404  CYTOTOXIC LYMPHOCYTES 
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Fxo.  7.  Cytotoxicity of L,PF-induced effector cells against allogeneic and syngeneic normal cells. 
BALB/c (H-2  a)  spleen cells were cultured with LPF for 72 h  and assayed  for cytotoxic  activity 
against (A) BALB/c macrophages  (O) and C57B1/6 H-2  b) macrophages  (O); and (B) BALB/c LPS 
blasts (O) and CBA (H-2  k] LPS blasts (0). 
Unlike the situation with concanavalin A and phytohemagglutinin P, LPF-stimulated 
cytotoxic effector lymphocytes required no further addition of mitogen for maximal 
cytotoxicity. The  effector cells  displayed specificity, destroying only allogeneic but 
not syngeneic normal cells;  in the case of tumor cells, both allogeneic and syngeneic AH SWEE KONG AND STEPHEN I.  MORSE  1405 
cells were lysed in the absence of added mitogen. The reason for differential cytotox- 
icity  toward  syngeneic  tumor  and  normal  cells  is  not  clear  but  may  have  some 
relevance to in vivo tumor rejection initiated  by Bordetella pertussis. 
We wish to thank Carol D. Stearns and Susan R. Goldsmith for expert  technical  assistance 
during these studies. 
Received  for publication 12 March 1979. 
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